| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/29/2004 | WO2003040369A3 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147730 Inhibitors against galectins |
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147714 High linear content; low molecular weight, narrow range; using alkali metal secondary amine polymerization aide |
| 07/29/2004 | US20040147610 Aging resistance; anticancer agents; neurodegradation disease;amyotropic lateral sclerosis; Alzheimer's disease |
| 07/29/2004 | US20040147591 Viricides; anticancer agents; immunostimulant |
| 07/29/2004 | US20040147589 Indolone derivatives having vascular damaging activity |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147574 Antagonist of transforming growth factor; antiproliferative agents |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147561 Pyrid-2-one derivatives and methods of use |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147543 Immonomoderators; viricides; anticancer agents |
| 07/29/2004 | US20040147541 Using rapamycin; antitumor agents; angiogenesis inhibitors |
| 07/29/2004 | US20040147530 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147499 Chlorins and purpurins |
| 07/29/2004 | US20040147486 Antitumor, anticancer agents; osteoporosis; bone disorders; Paget's disorders |
| 07/29/2004 | US20040147478 Administering to the patient a combination of a therapeutically effective amount of a MEK inhibitor and a therapeutically effective amount of capecitabine |
| 07/29/2004 | US20040147476 For therapy and prophylaxis of virus infections, other pathogenic infections or cancers |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147463 For therapy of cancer |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147438 For therapy of neuroblastoma |
| 07/29/2004 | US20040147431 Erythropoietin composition |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146994 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146856 Viral vector coding antiproliferative agent for treatment of tumors; antitumor agents and artificial chromosome gene therapy |
| 07/29/2004 | US20040146853 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 07/29/2004 | US20040146595 Breast cancer ; therapy containing plant extracts |
| 07/29/2004 | US20040146583 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146582 Kits; administering dosage cycles; leukemia therapy |
| 07/29/2004 | US20040146581 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146580 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146579 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146578 Kits; administering cycle; leukemia therapy |
| 07/29/2004 | US20040146577 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146576 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146575 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146574 Leukemic therapy; determination administering dosage |
| 07/29/2004 | US20040146573 Determining a therapeutic dosage of arsenic trioxide based upon the predetermined weight of the patient and administering; Leukemia; lymphomas; solid tumors; anticarcinoma and -tumor agents |
| 07/29/2004 | US20040146572 Determination of dosage bases on weight |
| 07/29/2004 | US20040146571 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146570 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146569 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146568 Antitumor agents; for solid tumors; administering cycles |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146505 Polypeptide comprising portion with part of human fc fragment which binds to CD64 antigen, and portion comprising heterologous T cell epitopes; antitumor and anticarcinogenic agents |
| 07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
| 07/29/2004 | US20040146485 Vaccines including as an adjuvant type 1 ifn and process related thereto |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | DE10303671A1 New 8alpha,14beta-dialkyl-18-nor steroids useful as pharmaceuticals, intermediates or carriers for treating e.g. tumors, alzheimers disease |
| 07/29/2004 | DE10303667A1 New 14-fluoro-15,17-dihydroxysteroid derivatives, useful for treating Alzheimer's disease and tumors, and as intermediates, are e.g. inhibitors of steroid dehydrogenase |
| 07/29/2004 | DE10302422A1 Composition for treating cancer, particularly carcinoma of the breast, and that reduces tumor mass in only a few days, comprises annexin V and a cytokine, such as an interleukin or granulocyte-macrophage colony-stimulating factor |
| 07/29/2004 | DE10301650A1 New 1-phenyl-2-aminomethylnaphthalene derivatives used for treating tumors, neurodegeneration, inflammation and Chagas disease |
| 07/29/2004 | DE10226592B4 Tumorhemmende Platin(II)-oxalato-Komplexe Antitumor platinum (II) complexes -oxalato |
| 07/29/2004 | CA2516398A1 Method of modulating il-6 |
| 07/29/2004 | CA2513701A1 Dimerized peptide |
| 07/29/2004 | CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | CA2513042A1 Blood-brain barrier disruption inhibitor |
| 07/29/2004 | CA2512819A1 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/29/2004 | CA2511858A1 Metastin derivative and use thereof |
| 07/29/2004 | CA2511818A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 07/28/2004 | EP1440973A2 Epothilone derivatives, preparation and use |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440114A1 Material consisting of at least a biodegradable polymer and cyclodextrins |